28
Oct
2025

Avixa Ilaç San. ve Tic. A.S.

Exhibitor at CPHI Frankfurt 2025 stand 3.1C92, Finished Dosage Formulations
About Us

Avixa Pharmaceuticals started its sectoral activities in 1981 with a pharmacy and a chemical raw material production facility. In 2010s, we become a group of companies including pharmacy, pharmaceutical warehouse, pharmaceutical company and R&D company. Avixa Pharmaceuticals have missions to developing world-class drugs, discover new treatment solutions to need of all patients, making all the necessary investments in it, keeping the satisfaction of the patients at the highest level and adhering to legal and ethical values at all times without compromising quality.https://www.avixa.com.tr/  to get to know more information click here.

AVIXA Pharmaceuticals has concentrated its research, development and investments in the pharmaceutical field. It has world class manufacturing facilities to manufacture Pharmaceutical related products and other OTC products in Turkey, and The manufacturing site has Turkish GMP & plus (PIC/S) from the Turkish Authority.

  • TR
  • 2022
    On CPHI since
  • 250 - 499
    Employees
Company types
Pharmaceutical company
Primary activities
Pharmaceutical Company (generic finished products)
Contact info
Event information
CPHI Frankfurt 2025
  • 28 Oct 2025 - 30 Oct 2025
  • Messe, Frankfurt
  • Visit us at stand 3.1C92, Finished Dosage Formulations

Products Featured at CPHI Frankfurt 2025